Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “multiple sclerosis”
Sponsor: AstraZeneca
Multiple Sclerosis
United States, Australia, Canada, Germany, United Kingdom
- AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe EpilepsyRecruiting
Sponsor: UniQure Biopharma B.V.
Mesial Temporal Lobe Epilepsy
United States
- RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesRecruiting
Sponsor: Reunion Neuroscience Inc
Adjustment Disorder
United States
Sponsor: Liliana Barrios
Multiple Sclerosis · Long Covid · Healthy
Switzerland
- A Basket Study of CTA313 in Participants With Active Autoimmune DiseasesNot Yet Recruiting
Sponsor: Imviva Bio
Systemic Lupus Erthematosus (SLE) · Progressive Multiple Sclerosis (PMS) · Autoimmune Encephalitis
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in Participants With Relapsing Multiple Sclerosis (RMS)Active Not Recruiting
Sponsor: TG Therapeutics, Inc.
Relapsing Multiple Sclerosis
Bosnia and Herzegovina, Bulgaria, Croatia, Czechia, Georgia +4 more
Sponsor: TG Therapeutics, Inc.
Multiple Sclerosis
United States
- A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast MilkRecruiting
Sponsor: TG Therapeutics, Inc.
Relapsing Multiple Sclerosis
United States
Sponsor: TG Therapeutics, Inc.
Multiple Sclerosis
Bosnia and Herzegovina, Georgia, North Macedonia, Poland, Serbia +1 more
- An Extension Study of Ublituximab in Participants With Relapsing Multiple SclerosisActive Not Recruiting
Sponsor: TG Therapeutics, Inc.
Relapsing Multiple Sclerosis (RMS)
United States, Belarus, Croatia, Georgia, Poland +3 more
Sponsor: Novartis Pharmaceuticals
Tuberous Sclerosis Complex
United States, Australia, Belgium, Canada, Colombia +13 more
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
United States
Sponsor: TG Therapeutics, Inc.
Relapsing Multiple Sclerosis
Poland
- Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTDNot Yet Recruiting
Sponsor: Medstar Health Research Institute
Spinal Cord Injury · Neurogenic Bladder (NB) · Neurogenic Lower Urinary Tract Dysfunction · Multiple Sclerosis
United States
Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD.
Relapsing-remitting Multiple Sclerosis (RRMS)
China
- A Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MSNot Yet Recruiting
Sponsor: Moein Amin
Multiple Sclerosis (MS) - Relapsing-remitting · Multiple Sclerosis (MS) Secondary Progressive · Multiple Sclerosis (MS) Primary Progressive
United States
- A Study to Investigate the Efficacy of Fenebrutinib in Relapsing Multiple Sclerosis (RMS)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Relapsing Multiple Sclerosis
United States, Bosnia and Herzegovina, Croatia, Czechia, Serbia +1 more
Sponsor: Wayne State University
Multiple Sclerosis · Gait Disorders, Neurologic · Accidental Fall
United States
Sponsor: Wayne State University
Multiple Sclerosis
United States
- Pain Phenotypes in Individuals With Multiple SclerosisNot Yet Recruiting
Sponsor: Kutahya Health Sciences University
Multiple Sclerosis · Chronic Pain
Turkey (Türkiye)
- Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Relapsing Multiple Sclerosis
United States, Argentina, Brazil, Bulgaria, Canada +22 more
Sponsor: Leal Therapeutics, Inc
Amyotrophic Lateral Sclerosis
Germany, Italy, Netherlands, Sweden
- Effects of Face-to-Face Versus Telerehabilitation-Based Circuit Training in People With Multiple SclerosisNot Yet Recruiting
Sponsor: Istanbul University - Cerrahpasa
Multiple Sclerosis
Turkey (Türkiye)
- Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Relapsing Multiple Sclerosis
United States, Argentina, Austria, Belgium, Brazil +29 more
- PLasmatic Extracellular Vesicles AS Biomarkers of nEural Tissue DamageNot Yet Recruiting
Sponsor: Roberto Furlan
Multiple Sclerosis · Stroke